Clinical Trial Update: Comparison of Adalimumab and Infliximab Treatment of Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

This Phase 4 trial update compares the effectiveness and safety of adalimumab versus infliximab in rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)
• Remicade (infliximab)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN